Regulatory tracker: Daiichi Sankyo's leukemia drug Vanflyta wins NICE backing
Welcome to Fierce Pharma's regulatory tracker for the second half of 2024. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and new indications. UPDATED: Thursday, September 19 …